Professional profile: https://cv.martinmilbradt.de/
Anonymous feedback form: https://www.admonymous.co/martin-milbradt
1-1s: https://calendly.com/martin-milbradt/30min
Last update: 2024-04-28
I don't know much about painkillers in LMICs, but in my understanding the US prescribes many more opioids than other western countries (like Germany, where I'm from). So this idea/problem might be specific to the US.
@mincho: How does Suzetrigine compare to existing non-opioid painkillers?
For anyone interested in how to go from research to large-scale production, there recently was an article about that in Works in Progress: https://worksinprogress.co/issue/getting-materials-out-of-the-lab/
Update: We'll be joining forces with the Qualia Research Institute, who are in Berlin this week: https://qualiacomputing.com/2024/05/17/qri-in-germany/
I think we'll get along great and there's a big overlap. Scott:
The Qualia Research Institute is doing absolutely picture-perfect mad science.
Just an info, nothing actually changes!
Disclaimer: Just skimmed the paper.
Their definition of "self-replication" seems to be just to copy the model weights to another place and start it on an open port - no unexpected capability.
To see the performance of AI agents on more complex AI R&D tasks, I recommend METR's recent publication: https://metr.org/AI_R_D_Evaluation_Report.pdf